Gottfried Wilhelm Leibniz

Gottfried Wilhelm Leibniz, who has the reputation of being perhaps the last universal genius, is the man after whom the Leibniz Association is named.

About Gottfried Wilhelm Leibniz

Research Approach

The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. These compounds are useful tools in basic biomedical research and may be further developed for the treatment, prevention, or diagnosis of disease.
To this aim researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models.


A brief history

The FMP was founded in 1992 as a successor to the "Institut für Wirkstofforschung", an Institute of the Academy of Sciences of the GDR. It was renamed "Forschungsinstitut für Molekulare Pharmakologie" - hence, its acronym FMP. Then as now, the institute focused on proteins as basic structures of the lives of all cellular organisms.

From the beginning, the FMP has been a member of the Leibniz-Association and is now called Leibniz-Forschungsinstitut für Molekulare Pharmakologie. The FMP and seven other Berlin Leibniz-Institutes are legally represented by the Forschungsverbund Berlin e.V. 




Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)

Like many sites, we use cookies to optimize the user's browsing experience. Data Protection OK